title: Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sites.
abstract: BACKGROUND
  Radiotherapy is a basic weapon in the local treatment of multiple solid tumors. The radiotherapy activity has been evaluated in our centre during the past eleven years. The study focused on rectal cancer.
  
  
  METHODS
  This is a descriptive study of all radiotherapy procedures performed between January 1998 and December 2008. It quantifies the workload of each pathology treated, the rate of irradiation and its adequacy with optimal rates of irradiation according to the best available scientific evidence.
  
  
  RESULTS
  We quantified 9,622 external radiotherapy procedures of which 6,009 were associated with the five pathologies that involved the highest workloads. Of these, 905 were performed in rectal cancer. The workloads due to cancers of the breast, prostate, lung, gynaecological pathologies and rectal cancers were 23.2%, 11.8%, 11.6%, 6.3% and 9.3% respectively. The real "radiotherapy utilisation rates" of these pathologies were 62%, 20.2%, 34.3%, 21% and 64% respectively, while the "rates of adequacy" were 74.7%, 33.6%, 45.1%, 60% and 104.8%.
  
  
  CONCLUSIONS
  The "radiotherapy utilisation rate" for rectal cancer was equivalent to the estimated optimum rate as defined on the basis of reference groups. The therapy utilised developed chronologically in parallel with the available scientific evidence. The radiotherapy utilisation rates for breast and prostate cancer gradually increased, with a tendency to reach optimal rates. Radiotherapy as a treatment for lung cancer was underutilised. In global terms, the rate of utilisation of radiation therapy was low, although it displayed a tendency to increase.
authors.affiliation: Department of Radiation Oncology, Reina Sofia University Hospital, Córdoba, Spain. songar1@gmail.com
authors.forename: Sonia
authors.initials: S
authors.lastname: García Cabezas
authors.forename: Amalia
authors.initials: A
authors.lastname: Palacios Eito
authors.forename: María
authors.initials: M
authors.lastname: Martínez Paredes
authors.forename: Eleonor
authors.initials: E
authors.lastname: Rivin del Campo
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy; D002277:Carcinoma / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D005833:Genital Neoplasms, Female / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000473:pathology / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy; D018787:Radiation Oncology / Q000379:methods / Q000639:trends; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects* / Q000379:methods* / Q000706:statistics & numerical data*; D012004:Rectal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy*; D012189:Retrospective Studies; D016526:Workload / Q000706:statistics & numerical data